379 related articles for article (PubMed ID: 8977598)
1. Effect of regular terbutaline on the airway response to inhaled budesonide.
Wilding PJ; Clark MM; Oborne J; Bennett JA; Tattersfield AE
Thorax; 1996 Oct; 51(10):989-92. PubMed ID: 8977598
[TBL] [Abstract][Full Text] [Related]
2. Rebound airway obstruction and responsiveness after cessation of terbutaline: effects of budesonide.
de Jong JW; van der Mark TW; Koëter GH; Postma DS
Am J Respir Crit Care Med; 1996 Jan; 153(1):70-5. PubMed ID: 8542165
[TBL] [Abstract][Full Text] [Related]
3. Effect of regular terbutaline and budesonide on bronchial reactivity to allergen challenge.
Wong CS; Wahedna I; Pavord ID; Tattersfield AE
Am J Respir Crit Care Med; 1994 Nov; 150(5 Pt 1):1268-73. PubMed ID: 7952551
[TBL] [Abstract][Full Text] [Related]
4. Bronchodilator tolerance and rebound bronchoconstriction during regular inhaled beta-agonist treatment.
Hancox RJ; Cowan JO; Flannery EM; Herbison GP; McLachlan CR; Taylor DR
Respir Med; 2000 Aug; 94(8):767-71. PubMed ID: 10955752
[TBL] [Abstract][Full Text] [Related]
5. Budesonide and terbutaline or terbutaline alone in children with mild asthma: effects on bronchial hyperresponsiveness and diurnal variation in peak flow.
Waalkens HJ; Gerritsen J; Koëter GH; Krouwels FH; van Aalderen WM; Knol K
Thorax; 1991 Jul; 46(7):499-503. PubMed ID: 1877037
[TBL] [Abstract][Full Text] [Related]
6. Effects of terbutaline and budesonide on sputum cells and bronchial hyperresponsiveness in asthma.
Aldridge RE; Hancox RJ; Robin Taylor D; Cowan JO; Winn MC; Frampton CM; Town GI
Am J Respir Crit Care Med; 2000 May; 161(5):1459-64. PubMed ID: 10806139
[TBL] [Abstract][Full Text] [Related]
7. Comparison of a beta 2-agonist, terbutaline, with an inhaled corticosteroid, budesonide, in newly detected asthma.
Haahtela T; Järvinen M; Kava T; Kiviranta K; Koskinen S; Lehtonen K; Nikander K; Persson T; Reinikainen K; Selroos O
N Engl J Med; 1991 Aug; 325(6):388-92. PubMed ID: 2062329
[TBL] [Abstract][Full Text] [Related]
8. Relative effects of inhaled corticosteroids on immunopathology and physiology in asthma: a controlled study.
Burke CM; Sreenan S; Pathmakanthan S; Patterson J; Schmekel B; Poulter LW
Thorax; 1996 Oct; 51(10):993-9. PubMed ID: 8977599
[TBL] [Abstract][Full Text] [Related]
9. Randomised trial of an inhaled beta2 agonist, inhaled corticosteroid and their combination in the treatment of asthma.
Hancox RJ; Cowan JO; Flannery EM; Herbison GP; McLachlan CR; Wong CS; Taylor DR
Thorax; 1999 Jun; 54(6):482-7. PubMed ID: 10335000
[TBL] [Abstract][Full Text] [Related]
10. Effects of the long acting beta agonist formoterol on asthma control in asthmatic patients using inhaled corticosteroids. The Netherlands and Canadian Formoterol Study Investigators.
van der Molen T; Postma DS; Turner MO; Jong BM; Malo JL; Chapman K; Grossman R; de Graaff CS; Riemersma RA; Sears MR
Thorax; 1997 Jun; 52(6):535-9. PubMed ID: 9227720
[TBL] [Abstract][Full Text] [Related]
11. Use of a fixed combination beta 2-agonist and steroid dry powder inhaler in asthma.
Barnes PJ; O'Connor BJ
Am J Respir Crit Care Med; 1995 Apr; 151(4):1053-7. PubMed ID: 7697230
[TBL] [Abstract][Full Text] [Related]
12. Long-term intervention in childhood asthma: the Dutch study results. Dutch Chronic Nonspecific Lung Disease Study Group.
van Essen-Zandvliet EE
Monaldi Arch Chest Dis; 1995 May; 50(3):201-7. PubMed ID: 7663491
[TBL] [Abstract][Full Text] [Related]
13. Effects of cessation of terbutaline treatment on airway obstruction and responsiveness in patients with chronic obstructive pulmonary disease.
de Jong JW; Koëter GH; van der Mark TW; Postma DS
Thorax; 1996 Jul; 51(7):684-8. PubMed ID: 8882073
[TBL] [Abstract][Full Text] [Related]
14. Tolerance to beta-agonists during acute bronchoconstriction.
Hancox RJ; Aldridge RE; Cowan JO; Flannery EM; Herbison GP; McLachlan CR; Town GI; Taylor DR
Eur Respir J; 1999 Aug; 14(2):283-7. PubMed ID: 10515402
[TBL] [Abstract][Full Text] [Related]
15. Effects of reducing or discontinuing inhaled budesonide in patients with mild asthma.
Haahtela T; Järvinen M; Kava T; Kiviranta K; Koskinen S; Lehtonen K; Nikander K; Persson T; Selroos O; Sovijärvi A
N Engl J Med; 1994 Sep; 331(11):700-5. PubMed ID: 8058076
[TBL] [Abstract][Full Text] [Related]
16. Randomised placebo controlled trial of beta agonist dose reduction in asthma.
Harrison TW; Oborne J; Wilding PJ; Tattersfield AE
Thorax; 1999 Feb; 54(2):98-102. PubMed ID: 10325911
[TBL] [Abstract][Full Text] [Related]
17. Time course of change in bronchial reactivity with an inhaled corticosteroid in asthma.
Vathenen AS; Knox AJ; Wisniewski A; Tattersfield AE
Am Rev Respir Dis; 1991 Jun; 143(6):1317-21. PubMed ID: 2048819
[TBL] [Abstract][Full Text] [Related]
18. Effect of an inhaled glucocorticosteroid on mast cell and smooth muscle beta 2 adrenergic tolerance in mild asthma.
Yates DH; Worsdell M; Barnes PJ
Thorax; 1998 Feb; 53(2):110-3. PubMed ID: 9624295
[TBL] [Abstract][Full Text] [Related]
19. Changes in bronchial hyperreactivity induced by 4 weeks of treatment with antiasthmatic drugs in patients with allergic asthma: a comparison between budesonide and terbutaline.
Kraan J; Koëter GH; vd Mark TW; Sluiter HJ; de Vries K
J Allergy Clin Immunol; 1985 Oct; 76(4):628-36. PubMed ID: 4056250
[TBL] [Abstract][Full Text] [Related]
20. Effects of treatment with formoterol on bronchoprotection against methacholine.
Lipworth B; Tan S; Devlin M; Aiken T; Baker R; Hendrick D
Am J Med; 1998 May; 104(5):431-8. PubMed ID: 9626025
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
